SOURCES SOUGHT
W -- Monarch Robotic Bronchoscopy Platform Lease BRAND NAME OR EQUAL
- Notice Date
- 12/10/2021 11:33:10 AM
- Notice Type
- Sources Sought
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- 246-NETWORK CONTRACTING OFFICE 6 (36C246) HAMPTON VA 23667 USA
- ZIP Code
- 23667
- Solicitation Number
- 36C24622Q0184
- Response Due
- 12/15/2021 1:00:00 PM
- Archive Date
- 12/20/2021
- Point of Contact
- John P Harmsen, Contract Specialist, Phone: 757-315-3978
- E-Mail Address
-
john.harmsen@va.gov
(john.harmsen@va.gov)
- Awardee
- null
- Description
- Sources Sought Notice Sources Sought Notice Page 4 of 4 Sources Sought Notice *= Required Field Sources Sought Notice Page 1 of 4 The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office 6 (NCO 6) is conducting a market survey and is seeking potential sources lease a Robotic controlled bronchoscopy system. This Sources Sought Notice is issued for information and planning purposes only. This is not a solicitation or a request for proposal and shall not be construed as an obligation or commitment by the Government. An award will not be made on any offers submitted in response to this notice, and it shall not be implied the Government is committed to providing any solicitation or award following this notice. The Government will not pay for any information received in response to this request, nor will the Government compensate a respondent for any costs incurred in developing the information provided. Responses shall be submitted to John Harmsen at john.harmsen@va.gov by COB 12/15/2021 SUBJECT: RFI 36C24622Q0184 Robotic Bronchoscopy system This notice is intended strictly for market research. The purpose of this Sources Sought Notice is to determine interest and capability of potential qualified sources of supply and determine the socioeconomic size classification of the supplier and manufacturer of the end item. Interested companies shall provide, at a minimum, the following information with their response. Company Name and Address: Point of Contact (POC) Name: Email Address: Phone Number: DUNS Number: Brochures of their offered equipment. The anticipated North American Industry Classification System (NAICS) code is 339112 Mark if your firm is eligible for participation in one of the following small business programs. If so, please indicate the program: [ ] yes [ ] no - Small Business (SB) [ ] yes [ ] no - HUBZone [ ] yes [ ] no - Small Business 8(a) [ ] yes [ ] no - Small Disadvantaged Business (SDB) [ ] yes [ ] no - Women-Owned (WO) Small Business [ ] yes [ ] no - Service Disabled Veteran Owned Small Business (SDVOSB) [ ] yes [ ] no - Veteran Owned Small Business (VOSB) [ ] yes [ ] no - Large Business [ ] yes [ ] no - Other (please specify) Please answer the following questions: [ ] yes [ ] no - Does not exceed 1,5000 employees; (for NAICS 339112 must be verifiable thru the System for Award Management) [ ] yes [ ] no Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; [ ] yes [ ] no Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice (identify how this occurs); and [ ] yes [ ] no Will supply the end item of a small business manufacturer, processor or producer made in the United States, or obtains a waiver of such requirement pursuant to paragraph (b)(5) CFR 121.406. Note: Do not include Proprietary, classified, confidential, or sensitive information in responses. In addition to providing the information requested above, responding companies are encouraged to include any relevant information (specifications, cut sheets, brochures, capability statement, experience etc.) to confirm the company s ability to meet the requirements outlined in this request. Responses to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract or agreement. This notice shall not be construed as a commitment by the Government to issue a solicitation, or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. Lease a BRAND NAME OR EQUAL Monarch Robotic System for Rigid and Flexible Therapeutic and Diagnostic Bronchoscopy, with Continuous Vision (FDA-Approved) Statement of Need (A) Functions to be performed, Robotic Bronchoscopies (B) Performance required; or Must provide direct visualization throughout the entire procedure. Must be medical grade Must have a telescoping sheath and scope architecture Must reach into apical and superior segments of the lung. Must possess integrated fluidics and aspiration controlled by handheld pendant controller Must utilize a controller-like interface Must be able to visualize instruments extend from the scope under direct camera visualization Must be expandable through field upgrades and clinical indications. (C) Essential physical characteristics; Dimensions Must accommodate diagnostic and therapeutic devices requiring a working channel diameter of 2.1 mm. Robotic controlled bronchoscope system requested features Fully dedicated and integrated camera within the bronchoscope to enable direct visualization throughout the entire procedure. Maximum visualization of instruments extending from the scope under direct camera visualization for diagnostic and therapeutic applications. The Robotic Platform accommodates diagnostic and therapeutic devices requiring a working channel diameter of 2.1 mm. Robotic system possesses telescoping sheath and scope architecture to enable stability and reach into apical and superior segments of the lung. Robotic System possess integrated fluidics and aspiration controlled by handheld pendant controller. Must be a robotic controlled bronchoscopy system. The device must have a fully dedicated and integrated camera within the bronchoscope to enable direct visualization throughout the entire procedure. Must be able to visualize instruments extend from the scope under direct camera visualization for diagnostic and therapeutic applications. The Robotic Platform must be able to accommodate diagnostic and therapeutic devices requiring a working channel diameter of 2.1 mm. Robotic system must possess telescoping sheath and scope architecture to enable stability and reach into apical and superior segments of the lung. Robotic Bronchoscopy system must possess integrated fluidics and aspiration controlled by handheld pendant controller. Technology Overview: Lung cancer is the leading cause of cancer deaths worldwide. More patients die every year from lung cancer than from prostate, breast, and colon cancer combined. Most patients diagnosed with lung cancer do not survive, in part because the disease has often progressed to a more advanced stage at the time of diagnosis. Nodule location and size combined with technology limitations have made early-stage diagnosis of lung cancer challenging. The Monarch Platform is a revolutionary flexible endoscopic technology designed to enable diagnostic physicians to diagnose, and eventually treat lung nodules with greater precision. Technology Indication for Use: The Monarch Platform is designed to address the limitations of current technology with the introduction of a new era of flexible robotics. The Monarch Platform utilizes a familiar controller-like interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, real-time vision, and precise control. In addition to advanced navigational views, based on 3-D models of the patient s own lung anatomy, the Monarch Platform provides physicians with continuous bronchoscope vision throughout the entire procedure. The Monarch Platform is designed to expand through field upgrades as new features and clinical indications are made available. Estimate of Use at VA Asheville NC It is estimated that the Asheville VA would start out doing approximately 125 cases a year with this new technology as it will take some time to determine which patients are more appropriate for traditional percutaneous vs robotic assisted biopsy. As the comfort level with the robot increases, it is very likely that there would be a reduced rate of pneumothoraxes requiring inpatient hospital stays after percutaneous biopsies. This would lead to a cost savings for the organization. On average, over the past two years, the interventional department has done approximately 10 guided lung biopsies per month and with this technology, both pulmonary and thoracic surgical services can start to do at least half of that number plus additional smaller nodules based on the capacity of this innovative technology. DISCLAIMER This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. End of Document
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/2dc30225935049f681d5ca1a3ff5c547/view)
- Place of Performance
- Address: VAMC Asheville 1100 Tunnel RD, Asheville 28805
- Zip Code: 28805
- Zip Code: 28805
- Record
- SN06196012-F 20211212/211210230112 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |